Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| TPET | PRESS-RELEASE | neutral | 3/10 | Trio Petroleum announced it has raised ~$24M via its ATM equity program and is pivoting to an acquisition strategy focus | May 11, 2026 |
| CMND | PRESS-RELEASE | neutral | 2/10 | Clearmind Medicine announced a live webinar on June 10, 2026, to discuss early clinical data from its Phase I/IIa trial | May 11, 2026 |
| EXPI | PRESS-RELEASE | bearish | 7/10 | eXp World Holdings reported Q1 2026 revenue of $1.0B (+5% YoY) and a GAAP net loss of $(5.1M) / $(0.03) per share, which | May 11, 2026 |
| IINN | PRESS-RELEASE | neutral | 5/10 | Inspira Technologies issued a shareholder letter outlining a strategic pivot into quantum connectivity and AME, reportin | May 11, 2026 |
| ATHE | PRESS-RELEASE | bullish | 7/10 | Alterity Therapeutics announced a peer-reviewed publication in NeuroImage demonstrating that QSM MRI can detect disease- | May 11, 2026 |
| APGE | PRESS-RELEASE | bullish | 7/10 | Apogee Therapeutics reported Q1 2026 EPS of -$1.03, a 9% beat vs consensus of -$1.13, with no revenue. The company highl | May 11, 2026 |
| MWG | PRESS-RELEASE | bullish | 6/10 | Multi Ways Holdings reported FY2025 revenue of $44.8M (+44.2% YoY) and a net loss narrowing to $0.4M from $2.9M, driven | May 11, 2026 |
| VFF | PRESS-RELEASE | mixed | 6/10 | Village Farms reported Q1 2026 revenue of $50.2M (+27% YoY) and GAAP EPS of $0.03 (vs consensus $0.02, a miss of -57.1% | May 11, 2026 |
| LXEO | PRESS-RELEASE | bullish | 6/10 | Lexeo Therapeutics reported Q1 2026 net loss of $0.25 per share, beating consensus estimates of -$0.30 by 16.7%, with re | May 11, 2026 |
| GANX | PRESS-RELEASE | neutral | 4/10 | Gain Therapeutics reported Q1 2026 EPS of -$0.13, beating consensus of -$0.14 by 7.1%, but the beat is marginal for a pr | May 11, 2026 |
| APC | PRESS-RELEASE | neutral | 5/10 | APC reported Q1 2026 net income of $8.1M ($0.20 EPS) vs $4.5M ($0.13) a year ago, beating consensus EPS of $0.20 exactly | May 11, 2026 |
| KEEL | PRESS-RELEASE | bearish | 7/10 | Keel Infrastructure reported Q1 2026 revenue of $37M (down 22% YoY) and GAAP EPS of -$0.21, a 425% miss vs consensus of | May 11, 2026 |
| GUTS | PRESS-RELEASE | bullish | 7/10 | Fractyl Health received Clinical Trial Authorization in the Netherlands to begin a Phase 1/2 first-in-human study of RJV | May 11, 2026 |
| DRTS | PRESS-RELEASE | bullish | 7/10 | Alpha Tau reported groundbreaking interim data from its REGAIN trial for recurrent glioblastoma, showing complete respon | May 11, 2026 |
| MBX | PRESS-RELEASE | mixed | 6/10 | MBX Biosciences reported preliminary Phase 1 data for MBX 4291 (GLP-1/GIP co-agonist prodrug) showing 7% mean weight los | May 11, 2026 |
| ERAS | PRESS-RELEASE | neutral | 4/10 | Erasca announced a clinical trial collaboration with Merck to evaluate its pan-RAS molecular glue ERAS-0015 in combinati | May 11, 2026 |
| KSPI | PRESS-RELEASE | bullish | 7/10 | Kaspi.kz reported Q1 2026 EPS of $1,457.68, an 18.8% beat vs consensus of $1,226.71, on revenue of KZT 1.1 trillion ($2. | May 11, 2026 |
| OLPX | PRESS-RELEASE | neutral | 4/10 | Olaplex reported Q1 2026 net sales of $99.4M (+2.5% YoY) but a GAAP net loss of $5.3M vs. $0.5M income a year ago, with | May 11, 2026 |
| LQDA | PRESS-RELEASE | bullish | 7/10 | Liquidia reported Q1 2026 revenue of $132.9M (driven by YUTREPIA sales of $129.9M) and net income of $52.9M ($0.52 dilut | May 11, 2026 |
| APO | PRESS-RELEASE | neutral | 4/10 | Apollo-managed funds have agreed to acquire Emerald Holding for $5.03 per share in cash (42.1% premium to unaffected pri | May 11, 2026 |
| CERT | PRESS-RELEASE | bearish | 7/10 | Certara reported Q1 2026 adjusted diluted EPS of $0.09, missing the $0.11 consensus by 15.1%, while revenue of $106.9M w | May 11, 2026 |
| ZH | PRESS-RELEASE | neutral | 1/10 | Zhihu Inc. announced it will report its Q1 2026 results on June 3, 2026. | May 11, 2026 |
| CLIK | PRESS-RELEASE | bullish | 5/10 | Click Holdings reported interim revenue of HK$59M (+57.3% YoY) for the six months ended Dec 31, 2025, driven by 117.8% g | May 11, 2026 |
| CGBD | PRESS-RELEASE | neutral | 4/10 | Carlyle Secured Lending reported Q1 2026 NII of $0.36 per share, a modest 2.1% beat vs $0.35 consensus, but NAV declined | May 11, 2026 |
| TSQ | PRESS-RELEASE | mixed | 5/10 | Townsquare Media reported Q1 2026 net revenue of $96.8M, down 1.9% YoY, and Adjusted EBITDA of $16.4M, down 9.7% YoY. Ne | May 11, 2026 |
| B | PRESS-RELEASE | bullish | 8/10 | Barrick Mining reported Q1 2026 results that significantly exceeded consensus estimates, with EPS of $0.96 (vs. $0.81 co | May 11, 2026 |
| B | PRESS-RELEASE | neutral | 4/10 | Barrick announced a $3.0 billion share buyback authorization and a $0.175 per share quarterly dividend. The buyback sign | May 11, 2026 |
| NIO | PRESS-RELEASE | neutral | 1/10 | NIO Inc. announced it will report its Q1 2026 results on May 21, 2026. | May 11, 2026 |
| ALVO | PRESS-RELEASE | neutral | 4/10 | Alvotech announced that the FDA completed a routine cGMP surveillance inspection of its Reykjavik facility, issuing a Fo | May 11, 2026 |
| ALVO | PRESS-RELEASE | bullish | 6/10 | Alvotech announced FDA completed a cGMP surveillance inspection of its manufacturing facility, issuing a Form 483 with o | May 11, 2026 |